Security record · archived quarter
MDXG
MiMedx Group, Inc. · Healthcare · Biotechnology
14Tracked holders
—Δ holders
7.86MShares held
$54.46MReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 90 | 0 | 52.35M | $201.57M | +8 | −8 |
| Q1 2026 | 93 | 0 | 53.34M | $210.99M | +4 | −4 |
| Q4 2025 | 93 | +1 | 51.21M | $346.71M | +1 | — |
| Q3 2025 | 19 | 0 | 33.28M | $232.30M | — | — |
| Q2 2025 | 16 | 0 | 31.16M | $190.41M | +1 | −1 |
| Q1 2025 | 13 | -1 | 11.80M | $89.67M | — | −1 |
| Q4 2024 | 14 | +1 | 11.42M | $109.89M | +1 | — |
| Q3 2024 | 12 | -2 | 7.09M | $41.90M | — | −2 |
| Q2 2024 | 14 | — | 7.86M | $54.46M | — | — |
Who holds it · Q2 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 2.75M | — | $19.06M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 2.75M | — | $19.06M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Renaissance Technologies ✦ | 1.57M | — | $10.88M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Arrowstreet Capital ✦ | 903.14K | — | $6.26M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Millennium Management ✦ | 889.45K | — | $6.16M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Two Sigma Investments ✦ | 640.04K | — | $4.44M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Fisher Asset Management ✦ | 315.83K | — | $2.19M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Marshall Wace ✦ | 298.82K | — | $2.07M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Wellington Management ✦ | 283.81K | — | $1.97M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Wellington Management ✦ | 283.81K | — | $1.97M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Norges Bank ✦ (passive) | 70.40K | — | $487,872 | 0.0% | n/c | 1 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 40.80K | — | $282,723 | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 40.33K | — | $279,452 | 0.0% | n/c | 1 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 37.75K | — | $262,000 | 0.0% | n/c | 1 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 10.37K | — | $71,829 | 0.0% | n/c | 1 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 10.37K | — | $71,829 | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Point72 Asset Management ✦ | 5.80K | — | $40,194 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 234 holders, 112.82M shares, $439.18M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2024 ·
Methodology ·
Get this via the API